| Product Information |
|
| Registration Number |
BR-877
|
| Generic Name |
Live Measles, Mumps and Rubella Vaccine
|
| Brand Name |
M-M-R II
|
| Dosage Strength |
Formulation: After reconstitution, one dose (0.5 mL) contains: Measles virus? Enders' Edmonston strain (live, attenuated).. Mumps virus! Jeryl Lynn TM (B Level) strain (live, attenuated) ...... Rubella virus? Wistar RA 27/3 strain (live, attenuated) ....
....
..
.NLT 1,000 CCID 50 ..NLT 12,500 CCID 50 ....NLT 1,000 CCID 50
() Produced in chick embryo cells. (2) Produced in WI-38 human diploid lung fibroblasts.
|
| Dosage Form |
Lyophilized Powder for Injection (IM/SC)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
Single dose. Clear and colorless glass vial x 3 mL +
Type I pre-filled glass syringe (diluent) (0.75 ml water for injection) x 1 mL + 2 separate needles in a sealed clear plastic tray (Box of 10's)
|
| Pharmacologic Category |
-
|
| Manufacturer |
Merck Sharp and Dohme Corp.
|
| Country of Origin |
USA
|
| Trader |
|
| Importer |
Merck Sharp & Dohme (I.A.) LLC
|
| Distributor |
Merck Sharp & Dohme (I.A.) LLC
|
| Application Type |
Renewal
|
| Issuance Date |
09 August 2022
|
| Expiry Date |
24 July 2027
|